✨ Health and Civil Union Notices
NEW ZEALAND GAZETTE, No. 14
9 FEBRUARY 2012
- Sale or marketing of this medicine may only occur if:
- the sponsor has an appropriate blood monitoring and patient record database in place; and
- the sponsor creates or participates in a central “red flag” database identifying patients who have previously been prescribed clozapine and who developed adverse drug reactions, which mean further use is contraindicated*.
Note: This renewed consent is valid for two years from 3 June 2012.
Product: Clopine
Active Ingredient: Clozapine 200mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Douglas Manufacturing Limited, Auckland, New Zealand
Note: This consent is given subject to the following conditions:
- The medicine may only be prescribed by:
- Registered medical practitioners as defined in the Health Practitioners Competence Assurance Act 2003 who are certified by the Medical Council of New Zealand as competent in the scope of practice of psychiatry.
- Medical practitioners employed as registrars in the branch of psychiatry who are under the supervision of persons of the kind referred to above.
- Medical officers of special scale who:
- work solely in the field of psychiatry;
- are in the employment of a District Health Board; and
- are under the supervision of persons who are registered medical practitioners as defined in the Health Practitioners Competence Assurance Act 2003 who are certified by the Medical Council of New Zealand as competent in the scope of practice of psychiatry.
-
Persons prescribing the medicine must comply with appropriate local treatment guidelines.
-
The medicine must be dispensed in accordance with appropriate local dispensing guidelines.
-
Sale or marketing of this medicine may only occur if:
- the sponsor has an appropriate blood monitoring and patient record database in place; and
- the sponsor creates or participates in a central “red flag” database identifying patients who have previously been prescribed clozapine and who developed adverse drug reactions, which mean further use is contraindicated*.
Note: This renewed consent is valid for two years from 3 June 2012.
Dated this 2nd day of February 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
New Zealand Gazette, 3 June 2010, No. 61, page 1776
go670
Internal Affairs
Civil Union Act 2004
Civil Union Celebrants for 2012 Notice No. 3
Pursuant to the provisions of sections 26 and 27 of the Civil Union Act 2004, the following person has been appointed as a civil union celebrant for the period 12 January 2012 to 31 January 2013:
Clark, Beverley Faye, 7 Gallery Grove, Flagstaff, Hamilton.
Dated at Wellington this 9th day of February 2012.
B. E. CLARKE, Registrar-General.
go713
Civil Union Celebrants for 2012 Notice No. 4
Pursuant to the provisions of section 28 of the Civil Union Act 2004, the following person has been removed from the list of civil union celebrants under section 29 of the Act. This removal comes into force on 9 February 2012:
Spurr, Shirley Muriel, 26 Islington Terrace, Waihi.
Dated at Wellington this 9th day of February 2012.
B. E. CLARKE, Registrar-General.
go715
Commissions of Inquiry Act 1908
Extension of Time Within Which Royal Commission on the Pike River Coal Mine Tragedy May Report
Elizabeth the Second, by the Grace of God Queen of New Zealand and her Other Realms and Territories, Head of the Commonwealth, Defender of the Faith:
To The Honourable GRAHAM KEN PANCKHURST, of Christchurch, Judge of the High Court of New Zealand; DAVID ROBERT HENRY, CNZM, Consultant; and STEWART LYNN BELL, Commissioner for Mine Safety and Health for Queensland:
GREETING:
WHEREAS by Our Warrant, dated 13 December 2010*, issued under the authority of the Letters Patent of Her Majesty Queen Elizabeth the Second constituting the office of Governor-General of New Zealand, dated 28 October 1983†, and under the authority of and subject to the provisions of the Commissions of Inquiry Act 1908, and with the advice and consent of the Executive Council of New Zealand, we nominated, constituted, and appointed you, the said The Honourable GRAHAM KEN PANCKHURST; DAVID ROBERT HENRY, CNZM; and STEWART LYNN BELL, to be a Commission to inquire into and report (making any recommendations that you think fit upon) certain matters relating to the Pike River coal mine tragedy:
Next Page →
✨ LLM interpretation of page content
🏥
Renewal of Provisional Consent for Clopine (Clozapine 200mg)
(continued from previous page)
🏥 Health & Social Welfare2 February 2012
Medicines, Renewal, Clopine, Clozapine, Douglas Pharmaceuticals
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
🏛️ Appointment of Civil Union Celebrant
🏛️ Governance & Central Administration9 February 2012
Civil Union, Celebrant, Appointment, Hamilton
- Beverley Faye Clark, Appointed Civil Union Celebrant
- B. E. CLARKE, Registrar-General
🏛️ Removal of Civil Union Celebrant
🏛️ Governance & Central Administration9 February 2012
Civil Union, Celebrant, Removal, Waihi
- Shirley Muriel Spurr, Removed from list of Civil Union Celebrants
- B. E. CLARKE, Registrar-General
🌏 Extension of Time for Pike River Coal Mine Tragedy Report
🌏 External Affairs & TerritoriesRoyal Commission, Pike River, Coal Mine, Tragedy, Extension
- Graham Ken Panckhurst (Honourable), Judge of the High Court of New Zealand
- David Robert Henry (CNZM), Consultant
- Stewart Lynn Bell, Commissioner for Mine Safety and Health for Queensland
NZ Gazette 2012, No 14